Harrisburg University of Science & Technology is pleased to welcome the 2025 MovePA Annual Conference on October 23–25: a statewide event assembling innovators, clinicians, and educators at the ...

My name is Silvia Escobar and I am a Licensed Clinical Social Worker (LCSW) based in Southern California. with 11 years of professional work experience. I work with adolescents and adults specializing ...

A new China youth fashion trend of getting tooth tattoos by engraving words like “get rich” and “ensure success” on their dental caps has trended on mainland social media. Facilitated by dental ...

Anti-transgender activists see this upcoming Supreme Court term as their chance to further insert religion into medicine and its regulation in the United States. On Oct. 7, the Supreme Court will hear ...

The US Food and Drug Administration plans to make changes soon to the lengthy black box warning on many hormone replacement products for women with menopause symptoms, Commissioner Dr. Martin Makary ...

Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...

Unlock Your Potential with Our #1 Self-Improvement App - Your only limit is you. Refocus, restart, and conquer. This motivational speech empowers you on your self-improvement journey, highlighting the ...

In 2025, Don't Stop Until You're Proud – Experience the Most Powerful Motivational Speeches! This intense and emotionally charged compilation by Absolute Motivation* is your catalyst for personal ...

UniQure's UQ1.F experimental gene therapy for Huntington's disease slowed progression of the brain disorder by 75% in an early-to-mid stage study, it said on Wednesday. Huntington's is a rare ...

A uniQure gene therapy slowed progression of Huntington’s disease by 75% after three years, statistically significant clinical trial results the company says will support plans for a regulatory ...

Scientists report the first therapy to slow the deadly brain disease. A one-time gene therapy treatment has shown remarkable success in slowing the progression of Huntington's disease in a preliminary ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...